Bariatric surgery programs face upheaval amid growing GLP-1 use for weight loss

At Roxborough Memorial Hospital in Philadelphia, surgeon Piotr Krecioch has his hands full launching a program offering surgical interventions to treat obesity. One in three Philadelphians are living ...
dvm360

Practical tips for preventing and managing obesity in dogs and cats

Ed Carlson, CVT, VTS (Nutrition), shares how routine body and muscle scoring, quantified nutrition histories, clear calorie ...

Weighty matters: GLP-1 drugs were made to treat diabetes, but their popularity for weight loss has created problems

TUPELO – Usage of GLP-1 drugs isn't new – they gained FDA approval in 2005, and evolved from 1980s diabetes research. But ...

I travelled to Japan in search of eternal youth

In the centenarian ‘Blue Zone’ of Okinawa, its sprightly residents swear by joy, movement and good food as secret to long life ...

Broward schools cut coverage of weight-loss drugs to save $12 million

Medications such as Wegovy and Zepbound will no longer be covered for weight loss, although GLP-1 drugs for diabetes will still be approved.
WSKG

Using GLP-1s to maintain a normal weight? There are benefits and risks

Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...
Reuters

Targeting Trump, UN chief says global problems will not be solved by one power 'calling the shots'

Guterres warns against erosion of international law and cooperation Multilateralism under assault, secretary-general says, amid global conflicts, US funding cuts Guterres prioritizes AI governance to ...
Benzinga.com

Roche's Obesity Drug Helps Almost 87% People Lose At Least 10% Weight

Roche Holdings AG (OTC: RHHBY) on Tuesday released topline results from the CT388-103 Phase 2 trial of CT-388 for obesity. CT-388 is an investigational once-weekly subcutaneous injectable, dual ...
Healio

Adults with obesity lost up to 22.5% of weight at 48 weeks with novel drug

Please provide your email address to receive an email when new articles are posted on . Adults receiving 24 mg of CT-388 achieved a placebo-adjusted weight loss of 22.5% according to the efficacy ...
USA Today

Wegovy works – at first. That won't end our obesity problem. | Opinion

The pharmaceutical giant Novo Nordisk has claimed that its new weight loss pill will do amazing things for the 100 million Americans living with obesity. However, a study published in January throws ...
SlashGear

Windows 11 Just Fixed One Of Its Biggest Problems

Consumer sentiment for Windows 11 has been on a downward trajectory of late, at least if the reactions to Microsoft executives are any indicator. Although it's hard to quantify broad user sentiment, ...
Yahoo! Sports

UFC 324 weigh-in results: Ex-champ badly misses weight, one other fighter heavy for Paramount debut

Two fighters missed weight and one fighter collapsed in a scary sight at Friday's official weigh-ins for UFC 324. Former two-time UFC flyweight champion Deiveson Figueiredo was Friday's most notable ...